Logo

American Heart Association

  160
  0


Final ID:

How long is long enough? Deescalation of DAPT intensity is preferred

  • Gorog, Diana  ( Imperial College , London , United Kingdom )
  • Halvorsen, Sigrun  ( Oslo University Hospital , Oslo , Norway )
  • Smilowitz, Nathaniel  ( NEW YORK UNIVERSITY MEDICAL CE , New York , New York , United States )
  • Rymer, Jennifer  ( Duke , Chapel Hill , North Carolina , United States )
  • Author Disclosures:
    Diana Gorog: DO have relevant financial relationships ; Advisor:BMS/Janssen:Active (exists now) ; Speaker:Chiesi:Active (exists now) ; Speaker:AstraZeneca:Past (completed) | Sigrun Halvorsen: No Answer | Nathaniel Smilowitz: DO have relevant financial relationships ; Consultant:Abbott Vascular:Active (exists now) ; Consultant:AngioInsight:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Jennifer Rymer: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Heating Up the Discussion: Key Debates in Acute Coronary Syndromes

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Panelist 4

Kaul Prashant, Smilowitz Nathaniel

How long is long enough? Abbreviated DAPT duration is preferred

Costa Francesco, Smits Pieter

You have to be authorized to contact abstract author. Please, Login
Not Available